Skip to main content
Log in

Expression of coxsackievirus and adenovirus receptor in human lung cancer: Possible clinical significance

  • Published:
Clinical Oncology and Cancer Research

Abstract

Objective

To explore the relationship between CAR and the development of human lung cancer, as well as to provide the basis for the clinical treatment of lung cancer using an adenovirus vector-based gene therapy.

Methods

CAR expression was assessed immunohistochemically in tumoral, paraneoplastic and normal samples from 112 lung cancer patients. At the same time, the mRNA and protein expression of CAR in 32 cases were determined by RT-PCR and Western blot. The relationship between CAR expression and clinicopathologic parameters was statistically analyzed.

Results

There was no expression of CAR in normal lung tissue but a little in paraneoplastic tissue. The positive rate was 43% in squamous cell carcinoma, and 70% in adenocarcinoma. Both were much significantly higher than that in paraneoplastic tissue. The CAR expression level in adenocarcinoma was higher than that in squamous cell cancer. mRNA expression by RT-PCR and protein expression by Western blot were consistent with immunohistochemistry results.

Conclusion

CAR is overexpressed in human lung cancer, especially in adenocarcinoma. This data offer the reliable basis for adenovirus-mediated gene therapy of lung cancer; more important, CAR may take part in the formation or development of lung cancer; this may be exploitable for the development of antibody-directed therapy in human lung cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Bergelson JM, Cunningham JA, Droguett G, et al. Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science 1997; 275: 1320–1323.

    Article  CAS  PubMed  Google Scholar 

  2. Bergelson JM, Krithivas A, Celi L, et al. The murine CAR homolog is a receptor for coxsackie B viruses and adenoviruses. J Virol 1998; 72: 415–419.

    CAS  PubMed  Google Scholar 

  3. Wang B, Chen G, Li F, et al. Inhibitory effect of coxsackie adenovirus receptor on invasion and metastasis phenotype of ovarian cancer cell line SKOV3. J Huazhong Univ Sci Technolog Med Sci 2005; 25: 85–87, 93.

    Article  PubMed  Google Scholar 

  4. Ito M, Kodama M, Masuko M, et al. Expression of coxsackievirus and adenovirus receptor in hearts of rats with experimental autoimmune myocarditis. Circ Res 2000; 86: 275–280.

    CAS  PubMed  Google Scholar 

  5. Okegawa T, Pong RC, Li Y, et al. The mechanism of the growth-inhibitory effect of coxsackie and adenovirus receptor (CAR) on human bladder cancer: a functional analysis of CAR protein structure. Cancer Res 2001; 61: 6592–6600.

    CAS  PubMed  Google Scholar 

  6. Coyne CB, Bergelson JM. CAR: A virus receptor within the tight junction. Adv Drug Deliv Rev 2005; 57: 869–882.

    Article  CAS  PubMed  Google Scholar 

  7. Kim JS, Lee SH, Cho YS, et al. Enhancement of the adenoviral sensitivity on human ovarian cancer cells by transient expression of coxsackievirus and adenovirus receptor (CAR). Gynecol Oncol 2002; 85: 260–265.

    Article  CAS  PubMed  Google Scholar 

  8. Hemmi S, Geertsen R, Mezzacasa A, et al. The presence of human coxsackievirus and adenovirus receptor is associated with efficient adenovirus-mediated transgene expression in human melanoma cell cultures. Hum Gene Ther 1998; 9: 2363–2373.

    Article  CAS  PubMed  Google Scholar 

  9. Li Y, Pong RC, Bergelson JM, et al. Loss of adenoviral receptor expression in human bladder cancer cells: a potential impact on the efficacy of gene therapy. Cancer Res 1999; 59: 325–330.

    CAS  PubMed  Google Scholar 

  10. Leon RP, Hedlund T, Meech SJ, et al. Adenoviral-mediated gene transfer in lymphocytes. Proc Natl Acad Sci USA 1998; 95: 13159–13164.

    Article  CAS  PubMed  Google Scholar 

  11. Wang X, Bergelson JM. Coxsackievirus and adenovirus receptor cytoplasmic and transmembrane domains are not essential for coxsackievirus and adenovirus infection. J Virol 1999; 73: 2559–25562.

    CAS  PubMed  Google Scholar 

  12. Bai M, Campisi L, Freimuth P. Vitronectin receptor antibodies inhibit infection of HeLa and A549 cells by adenovirus type 12 but not by adenovirus type 2. J Virol 1994; 68: 5925–5932.

    CAS  PubMed  Google Scholar 

  13. Barnett BG, Crews CJ, Douglas JT. Targeted adenoviral vectors. Biochim Biophys Acta 2002; 1575: 1–14.

    CAS  PubMed  Google Scholar 

  14. Zhang WW. Development and application of adenoviral vectors for gene therapy of cancer. Cancer Gene Ther 1999; 6: 113–138.

    Article  CAS  PubMed  Google Scholar 

  15. Hedley SJ, Chen J, Mountz JD, et al. Targeted and shielded adenovectors for cancer therapy. Cancer Immunol Immunother 2006; 55: 1412–1419.

    Article  CAS  PubMed  Google Scholar 

  16. Okegawa T, Li Y, Pong RC, et al. Cell adhesion proteins as tumor suppressors. J Urol 2002; 167: 1836–1843.

    Article  CAS  PubMed  Google Scholar 

  17. Merritt JA, Roth JA, Logothetis CJ. Clinical evaluation of adenoviral-mediated p53 gene transfer: review of INGN 201 studies. Semin Oncol 2001; 28: 105–114.

    Article  CAS  PubMed  Google Scholar 

  18. Persson A, Fan X, Widegren B, et al. Cell type- and region dependent coxsackie adenovirus receptor expression in the central nervous system. J Neurooncol 2006; 78: 1–6.

    Article  CAS  PubMed  Google Scholar 

  19. Persson A, Fan X, Salford LG, et al. Neuroblastomas and medulloblastomas exhibit more coxsackie adenovirus receptor expression than gliomas and other brain tumors. Neuropathology 2007; 27: 233–236.

    Article  PubMed  Google Scholar 

  20. Huang KC, Altinoz M, Wosik K, et al. Impact of the coxsackie and adenovirus receptor (CAR) on glioma cell growth and invasion: requirement for the C-terminal domain. Int J Cancer 2005; 113: 738–745.

    Article  CAS  PubMed  Google Scholar 

  21. Kim M, Sumerel LA, Belousova N, et al. The coxsackievirus and adenovirus receptor acts as a tumour suppressor in malignant glioma cells. Br J Cancer 2003; 88: 1411–1416.

    Article  CAS  PubMed  Google Scholar 

  22. Bruning A, Stickeler E, Diederich D, et al. Coxsackie and adenovirus receptor promotes adenocarcinoma cell survival and is expressionally activated after transition from preneoplastic precursor lesions to invasive adenocarcinomas. Clin Cancer Res 2005; 11: 4316–4320.

    Article  PubMed  Google Scholar 

  23. Wang Y, Wang S, Bao Y, et al. Coxsackievirus and adenovirus receptor expression in non-malignant lung tissues and clinical lung cancers. J Mol Hist 2006; 37: 153–160.

    Article  CAS  Google Scholar 

  24. Qin M, Chen S, Yu T. Coxsackievirus Adenovirus Receptor Expression Predicts the Efficiency of Adenoviral Gene Transfer into Non-Small Cell Lung Cancer Xenografts. Clinical Cancer Research 2003; 9: 4992–4999.

    CAS  PubMed  Google Scholar 

  25. Qin M, Escuadro B, Dohadwala M, et al. A Novel Role for the Coxsackie Adenovirus Receptor in Mediating Tumor Formation by Lung Cancer Cells. Cancer Research 2004; 64: 6377–6380.

    Article  CAS  PubMed  Google Scholar 

  26. Miller CR, Buchsbaum DJ, Reynolds PN, et al. Differential susceptibility of primary and established human glioma cells to adenovirus infection: targeting via the epidermal growth factor receptor achieves fiber receptor- independent gene transfer. Cancer Res 1998; 58: 5738–5748.

    CAS  PubMed  Google Scholar 

  27. Dmitriev I, Krasnykh V, Miller CR, et al. An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism. J Virol 1998; 72: 9706–9713.

    CAS  PubMed  Google Scholar 

  28. Wang BB, Chen G, Li FJ, et al. Inhibitory effect of coxsackie adenovirus receptor on invasive and metastatic phenotype of ovarian cancer cell line SKOV3. Ai Zheng 2005; 24: 1054–1058 (Chinese).

    CAS  PubMed  Google Scholar 

  29. Hemmi S, Geertsen R, Mezzacasa A, et al. The presence of human coxsackievirus and adenovirus receptor is associated with efficient adenovirus-mediated transgene expression in human melanoma cell cultures. Hum Gene Ther 1998; 9: 2363–2373.

    Article  CAS  PubMed  Google Scholar 

  30. Tanaka H, Shirakawa T, Zhang Z, et al. A replication-selective adenoviral vector for head and neck cancers. Arch Otolaryngol Head Neck Surg 2005; 131: 630–634.

    Article  PubMed  Google Scholar 

  31. Jee YS, Lee SG, Lee JC, et al. Reduced expression of coxsackievirus and adenovirus receptor (CAR) in tumor tissue compared to normal epithelium in head and neck squamous cell carcinoma patients. Anticancer Res 2002; 22: 2629–2634.

    CAS  PubMed  Google Scholar 

  32. Li D, Duan L, Freimuth P, et al. Variability of adenovirus receptor density influences gene transfer efficiency and therapeutic response in head and neck cancer. Clin Cancer Res 1999; 5: 4175–4181.

    CAS  PubMed  Google Scholar 

  33. Kawashima H, Ogose A, Yoshizawa T, et al. Expression of the coxsackievirus and adenovirus receptor in musculoskeletal tumors and mesenchymal tissues: efficacy of adenoviral gene therapy for osteosarcoma. Cancer Sci 2003; 94: 70–75.

    Article  CAS  PubMed  Google Scholar 

  34. Ito T, Tokunaga K, Maruyama H, et al. Coxsackievirus and adenovirus receptor (CAR)-positive immature osteoblasts as targets of adenovirus-mediated gene transfer for fracture healing. Gene Therapy 2003; 10: 1623–1628.

    Article  CAS  PubMed  Google Scholar 

  35. Cripe TP, Dunphy EJ, Holub AD, Saini A, et al. Fiber knob modifications overcome low, heterogeneous expression of the coxsackievirus-adenovirus receptor that limits adenovirus gene transfer and oncolysis for human rhabdomyosarcoma cells. Cancer Res 2001; 61: 2953–2960.

    CAS  PubMed  Google Scholar 

  36. Zhang LL, He DL, Li X, et al. Overexpression of coxsackie and adenovirus receptor inhibit growth of human bladder cancer cell in vitro and in vivo. Acta Pharmacol Sin 2007; 28: 895–900.

    Article  PubMed  CAS  Google Scholar 

  37. Rauen KA, Sudilovsky D, Le JL, et al. Expression of the coxsackie adenovirus receptor in normal prostate and in primary and metastatic prostate carcinoma: potential relevance to gene therapy. Cancer Res 2002; 62: 3812–3818.

    CAS  PubMed  Google Scholar 

  38. Yamashita M, Ino A, Kawabata K, et al. Expression of coxsackie and adenovirus receptor reduces the lung metastatic potential of murine tumor cells. Int J Cancer 2007; 121: 1690–1696.

    Article  CAS  PubMed  Google Scholar 

  39. Tango Y, Taki M, Shirakiya Y, et al. Late resistance to adenoviral p53-mediated apoptosis caused by decreased expression of Coxsakie-adenovirus receptors in human lung cancer cells. Cancer Sci 2004; 95: 459–463.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Bao-cun Sun.

About this article

Cite this article

Sun, Ln., Gu, Ak., Chen, Zl. et al. Expression of coxsackievirus and adenovirus receptor in human lung cancer: Possible clinical significance. Clin. Oncol. Cancer Res. 7, 48–54 (2010). https://doi.org/10.1007/s11805-010-0048-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11805-010-0048-4

Key Words

Navigation